I LINFOMI LINFOBLASTICI IN ETA' PEDIATRICA: RISULTATI DEL PROTOCOLLO ITALIANO AIEOP LNH97

Autor: Pillon, M, Garaventa, A, Mussolin, Lara, Sala, A, Boaro, Mp, Franceschetto, G, Piglione, M, D'Amore, Es, Arico', M, Lombardi, A, Russo, D, Giraldi, E, Zecca, M, Varotto, S, LO NIGRO, L, Burnelli, R, Buffardi, S, Casale, F, Rosolen, Angelo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::b33071692e12a169e6b668b6e73c1e9f
http://hdl.handle.net/11577/2420387

Prognostic impact of humoral response to alk and its relationship with minimal residual disease in pediatric ALCL

Autor: Mussolin, Lara, Pillon, M., Bonvini, P., Tridello, G., Boaro, Mp, Sala, A., Lippi, A., Buffardi, S., Garaventa, A., Rosolen, Angelo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::5a176f4106a9e356ea443cc1799afdbf
http://hdl.handle.net/11577/2520916

Successful treatment of CMV retinitis after haploidentical CD34+-selected haematopoietic stem cell transplant (HSCT) for T-cell acute lymphoblastic leukaemia (T-ALL)

Autor: Cesaro, Simone, Boaro, Mp, Pillon, M, Calore, E, Tridello, G, Cermakova, I, Mengoli, C, Cusinato, R, Messina, C.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::95623405d7ea1852404b5837a9ec79c0
http://hdl.handle.net/11577/2267490

Early-onset indicators of a hypercoagulable state and clinical complications in a cohort of children with sickle cell trait.

Autor: Reggiani G; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Boaro MP; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Menzato F; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., De Bon E; UOC General Medicine, Cittadella's Hospital, Cittadella, Italy., Bertomoro A; Department of Medicine, Internal Medicine 1 Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Casonato A; Department of Medicine, Internal Medicine 1 Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Lucente F; Department of Medicine, Internal Medicine 1 Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Fortino C; Department of Medicine, Internal Medicine 1 Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Sartori M; Department of Medicine, Internal Medicine 1 Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Steffan A; Department of Diagnostic Laboratory and Cellular Therapy, Centro Riferimento Oncologico, Aviano, Italy., Martella M; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., D'Agnolo M; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Sainati L; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy., Colombatti R; Department of Women's and Child's Health, Pediatric Hematology-Oncology Unit, Azienda Ospedaliera-Università di Padova, Padua, Italy.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jun; Vol. 71 (6), pp. e30971. Date of Electronic Publication: 2024 Mar 30.

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis.

Autor: Quotti Tubi L; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Canovas Nunes S; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Mandato E; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pizzi M; Department of Medicine, Cytopathology and Surgical Pathology Unit, University of Padova, Italy., Vitulo N; Department of Biotechnology, University of Verona, Italy., D'Agnolo M; Department of Women's and Child's Health, University of Padova, Italy., Colombatti R; Department of Women's and Child's Health, University of Padova, Italy., Martella M; Department of Women's and Child's Health, University of Padova, Italy., Boaro MP; Department of Women's and Child's Health, University of Padova, Italy., Doriguzzi Breatta E; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Fregnani A; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Spinello Z; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Nabergoj M; Hematology Service, Institut Central des Hôpitaux (ICH), Hôpital du Valais, Sion, Switzerland., Filhol O; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1036, Institute de Reserches en Technologies et Sciences pour le Vivant/Biologie du Cancer et de l'Infection, Grenoble, France., Boldyreff B; Kinase Detect, Krusaa, Denmark., Albiero M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy.; Veneto Institute of Molecular Medicine, Experimental Diabetology Lab, Padova, Italy., Fadini GP; Veneto Institute of Molecular Medicine, Experimental Diabetology Lab, Padova, Italy.; Department of Medicine, University of Padova, Italy., Gurrieri C; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Vianello F; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Semenzato G; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Manni S; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Trentin L; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Piazza F; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Publikováno v: HemaSphere [Hemasphere] 2023 Nov 23; Vol. 7 (12), pp. e978. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).